Recent Advances in Immune-based Therapies for Type 1 Diabetes.
Sign Up to like & getrecommendations! Published in 2022 at "Hormone research in paediatrics"
DOI: 10.1159/000524866
Abstract: BACKGROUND Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by progressive destruction of the pancreatic beta-cells leading to a lifelong dependence on insulin. It is associated with an increased morbidity and mortality from… read more here.
Keywords: disease; type diabetes; advances immune; beta cell ... See more keywords
Would the skyrocketed advances of immune checkpoint inhibitors over chemotherapy be stumbled by the safety issues
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/15193
Abstract: Immune checkpoint inhibitors (ICIs) have inaugurated a new era in the treatment of advanced malignancies. It is not only associated with higher progression-free survival and overall-survival but also a durable response that reached to 10… read more here.
Keywords: immune checkpoint; advances immune; would skyrocketed; checkpoint inhibitors ... See more keywords
Research advances in immune agonists and their nanoparticles for enhancing the immunotherapeutic efficacy of PD-1 inhibitors in malignancies
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2025.1618903
Abstract: Immune checkpoint blockade (ICB), particularly targeting programmed cell death-1 (PD-1), has revolutionized cancer immunotherapy but remains limited by heterogeneous therapeutic responses and immune-related toxicities. This review systematically examines the integration of immune agonists—STING, TLR, CD40,… read more here.
Keywords: oncology; advances immune; immune agonists; efficacy ... See more keywords